SCHEDULE: FMR LLC Discloses 5.6% Stake in Insulet Corp

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 5.6% of Insulet Corp's common stock as of March 31, 2026.

Summary

• FMR LLC, along with Abigail P. Johnson, has filed an amended Schedule 13G, indicating their beneficial ownership of 3,963,512.09 shares of Insulet Corp's common stock.
• This holding represents 5.6% of the class of securities outstanding as of March 31, 2026.
• FMR LLC is classified as a holding company, while Abigail P. Johnson is identified as an individual investor.
• The filing confirms that these securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of beneficial ownership by a large institutional investor and does not contain operational or financial performance updates.

Positives

• FMR LLC and Abigail P. Johnson maintain a significant stake, demonstrating confidence in Insulet Corp's long-term prospects.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a stable, non-activist investment approach.

Risks

• The filing does not explicitly detail any risks associated with the investment or the company's operations.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future performance.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by FMR LLC, a major institutional investor, indicates a significant, albeit passive, stake in Insulet Corp, a company operating in the medical device sector, specifically diabetes care technology. Such filings are common for large asset managers and signal their investment positions without necessarily implying an activist strategy.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional holding, which can be viewed positively as a sign of investor confidence, but it does not directly impact current operations or strategy.
• Management: The filing does not suggest any intent to influence control, thus not directly impacting management's current operational mandate.
• Creditors: No direct impact on creditors as the filing is purely an ownership disclosure.

Next Steps

• FMR LLC and Abigail P. Johnson will continue to hold their beneficial ownership of Insulet Corp's common stock.

Key Dates

Keywords

Insulet Corp, FMR LLC, Schedule 13G, beneficial ownership, common stock, Abigail P. Johnson, investment holding, SEC filing